Immunotech Biopharm Ltd (HKG:6978)
Hong Kong · Delayed Price · Currency is HKD 0.3550
-0.0100 (-2.74%)
Jul 31, 2026, 3:42 PM HKT
Immunotech Biopharm Market Cap
Immunotech Biopharm has a market cap or net worth of 219.21 million as of July 31, 2026. Its market cap has decreased by -89.51% in one year.
Market Cap
219.21M
Enterprise Value
533.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.36
ChartMarket Cap Chart
Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 219.21M, a decrease of -97.17%. That is a compound annual growth rate of -44.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 219.21M | -87.88% |
| Dec 31, 2025 | 1.81B | 52.87% |
| Dec 31, 2024 | 1.18B | -54.00% |
| Dec 29, 2023 | 2.57B | 7.99% |
| Dec 30, 2022 | 2.38B | -72.51% |
| Dec 31, 2021 | 8.67B | 50.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 839.48M |
| Wuhan YZY Biopharma | 715.30M |
| Brii Biosciences | 678.50M |
| JW (Cayman) Therapeutics Co. | 653.49M |
| Shanghai Bio-heart Biological Technology | 552.56M |
| 3D Medicines | 531.19M |
| Transcenta Holding | 460.78M |
| Uni-Bio Science Group | 453.81M |